Have your own idea? Try our Stock Screener
Polish (WIG) Pharma Industry Analysis
UpdatedFeb 21, 2025
DataAggregated Company Financials
Companies6
- 7D-3.8%
- 3M-12.3%
- 1Y17.0%
- YTD-9.8%
Over the last 7 days, the Pharma industry has dropped 5.6%, driven by Celon Pharma declining 7.0%. In the past year, the industry has gained 16%. Looking forward, earnings are forecast to decline by 30% per year.
Industry Valuation and Performance
Has the Polish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 21 Feb 2025 | zł1.5b | zł325.6m | -zł209,458,187.00 | 39.7x | -7.2x | 4.6x |
| Sun, 19 Jan 2025 | zł1.6b | zł318.9m | -zł9,295,998.00 | 44x | -176.4x | 5.1x |
| Tue, 17 Dec 2024 | zł1.6b | zł360.7m | -zł14,404,163.00 | 40.2x | -108.7x | 4.3x |
| Thu, 14 Nov 2024 | zł1.7b | zł314.5m | -zł72,767,518.00 | 11.9x | -23.5x | 5.4x |
| Sat, 12 Oct 2024 | zł1.8b | zł314.9m | -zł72,051,939.00 | 10.1x | -25.4x | 5.8x |
| Mon, 09 Sep 2024 | zł1.9b | zł317.3m | -zł60,178,104.00 | 11.6x | -30.8x | 5.8x |
| Wed, 07 Aug 2024 | zł1.7b | zł310.8m | -zł61,217,640.00 | 11.5x | -28.4x | 5.6x |
| Fri, 05 Jul 2024 | zł1.1b | zł310.8m | -zł61,217,640.00 | 11.9x | -18.2x | 3.6x |
| Sun, 02 Jun 2024 | zł1.1b | zł312.1m | -zł61,350,052.00 | 10x | -18.5x | 3.6x |
| Tue, 30 Apr 2024 | zł1.1b | zł313.6m | -zł43,157,065.00 | 14.6x | -26.1x | 3.6x |
| Thu, 28 Mar 2024 | zł1.2b | zł311.5m | -zł40,173,065.00 | 16.5x | -29.2x | 3.8x |
| Sat, 24 Feb 2024 | zł1.2b | zł311.5m | -zł40,173,065.00 | 15x | -29.8x | 3.8x |
| Mon, 22 Jan 2024 | zł1.2b | zł308.7m | -zł39,880,934.00 | 12.8x | -28.9x | 3.7x |
| Wed, 20 Dec 2023 | zł1.2b | zł308.7m | -zł39,880,934.00 | 11.6x | -30.2x | 3.9x |
| Fri, 17 Nov 2023 | zł1.1b | zł302.0m | -zł44,782,495.00 | 11.9x | -24.7x | 3.7x |
| Sun, 15 Oct 2023 | zł1.1b | zł302.0m | -zł42,933,291.00 | 10.5x | -26.6x | 3.8x |
| Tue, 12 Sep 2023 | zł1.2b | zł287.0m | -zł53,857,118.00 | 11.4x | -22.3x | 4.2x |
| Thu, 10 Aug 2023 | zł1.2b | zł278.4m | -zł53,806,540.00 | 36.8x | -21.4x | 4.1x |
| Sat, 08 Jul 2023 | zł1.1b | zł278.4m | -zł53,806,540.00 | 37.8x | -20.4x | 3.9x |
| Mon, 05 Jun 2023 | zł1.2b | zł282.1m | -zł51,108,194.00 | 36.5x | -23.1x | 4.2x |
| Wed, 03 May 2023 | zł1.1b | zł276.0m | -zł51,431,989.00 | 9.1x | -21.4x | 4x |
| Fri, 31 Mar 2023 | zł1.1b | zł273.2m | -zł44,427,333.00 | 8.4x | -25.7x | 4.2x |
| Sun, 26 Feb 2023 | zł1.1b | zł273.2m | -zł44,427,333.00 | 8.2x | -25.4x | 4.1x |
| Tue, 24 Jan 2023 | zł1.2b | zł270.3m | -zł44,201,704.00 | 7.7x | -26.3x | 4.3x |
| Thu, 22 Dec 2022 | zł990.9m | zł270.3m | -zł44,201,704.00 | 7.7x | -22.4x | 3.7x |
| Sat, 19 Nov 2022 | zł992.1m | zł260.9m | -zł40,809,798.00 | 8.1x | -24.3x | 3.8x |
| Mon, 17 Oct 2022 | zł857.8m | zł260.9m | -zł40,391,998.00 | 9.7x | -21.2x | 3.3x |
| Wed, 14 Sep 2022 | zł1.1b | zł265.6m | -zł29,272,739.00 | 10.1x | -36.5x | 4x |
| Fri, 12 Aug 2022 | zł1.2b | zł263.9m | -zł29,999,209.00 | 12.3x | -39.8x | 4.5x |
| Sun, 10 Jul 2022 | zł1.1b | zł264.2m | -zł29,985,890.00 | 10.4x | -38x | 4.3x |
| Tue, 07 Jun 2022 | zł1.4b | zł264.2m | -zł29,985,890.00 | 12x | -46.2x | 5.2x |
| Thu, 05 May 2022 | zł1.6b | zł235.3m | -zł1,158,483.00 | 57x | -1360.9x | 6.7x |
| Sat, 02 Apr 2022 | zł1.8b | zł358.1m | zł72.0m | 13.9x | 25.5x | 5.1x |
| Mon, 28 Feb 2022 | zł1.6b | zł358.1m | zł72.0m | 12.4x | 22.9x | 4.6x |
Price to Earnings Ratio
22.9x
Current Industry PE
- Investors are relatively neutral on the Polish Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 4.4x.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 3.8% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | 0.52% | |
| Healthcare | -0.99% | |
| Pharma | -3.81% | |
| Pharma | -3.81% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CBD Cannabis Poland | zł0.38 | 1.9% +zł344.4k | -41.1% | PS74.1x |